Research on gliomas has focused on protein tyrosine kinase (PTK) signaling pathways, particularly as PTK overactivity has been shown to induce cell growth; indeed, several PTKs have been identified as proto-oncogenes [42]. Here, PTK2B is linked to central nervous system cancer.